Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of BI 3000202 in healthy men and women
NL-OMON60929Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of BI 3000202, sponsored by Boehringer Ingelheim. Started Dec 2025; status: completed.
02
Drugs
BI 3000202
Beyond the preview
Go deeper on NL-OMON60929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60929.